<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药时代 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-27T07:26:23+08:00</updated>
  <subtitle>欢迎您走进药时代！这是一个千载难逢的医药研发新时代！我们分享最新的有价值的行业资讯，讲述医药背后感人的故事，举办形式多样、内容丰富的线上线下活动，与朋友们一起学习成长，将新药研发事业进行到底，让新药带给世界更多更大的健康</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>遗传毒性杂质专栏——遗传毒性杂质风险评估简析（下）</title>
    <updated>2020-11-27T07:14:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/_cdPWbXxXy1RzW2IdtBa5Q</id>
    <link href="https://mp.weixin.qq.com/s/_cdPWbXxXy1RzW2IdtBa5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Cell Research | 人源胰高血糖素样肽-2受体复合物三维结构成功解析</title>
    <updated>2020-11-27T07:14:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/1dPBRkJCA5n_IAGJKmbn-g</id>
    <link href="https://mp.weixin.qq.com/s/1dPBRkJCA5n_IAGJKmbn-g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第二代选择性核输出抑制剂ATG-016(Eltanexor)治疗骨髓增生异常综合征的疗法在中国大陆获I/II期临床试验批准</title>
    <updated>2020-11-27T07:14:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/DCIO6Soc6iShC5MLCS4Y0g</id>
    <link href="https://mp.weixin.qq.com/s/DCIO6Soc6iShC5MLCS4Y0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药明直播间|医疗器械测试系列(六)：病理学家如何推动医疗器械研发加速</title>
    <updated>2020-11-27T07:14:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/DIxWW9Ti_yA9u3NvJzI5lw</id>
    <link href="https://mp.weixin.qq.com/s/DIxWW9Ti_yA9u3NvJzI5lw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>遗传毒性杂质专栏——遗传毒性杂质风险评估简析（上）</title>
    <updated>2020-11-26T07:20:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/Fp-bwyiCGnfe_XsH30irYw</id>
    <link href="https://mp.weixin.qq.com/s/Fp-bwyiCGnfe_XsH30irYw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>COVID-19让一切加速：去中心化临床试验平台Medable达成今年第二笔融资</title>
    <updated>2020-11-26T07:20:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/DUd2fXTPCZGWYj-JPOB3JA</id>
    <link href="https://mp.weixin.qq.com/s/DUd2fXTPCZGWYj-JPOB3JA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PI3K抑制剂：从靶向治疗走向肿瘤微环境</title>
    <updated>2020-11-26T07:20:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/eZT49BOxQGhCm1L2azHQeA</id>
    <link href="https://mp.weixin.qq.com/s/eZT49BOxQGhCm1L2azHQeA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>博腾药时代直播间 | 新药开发过程中的CMC一体化项目管理的分享</title>
    <updated>2020-11-26T07:20:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/CSSqFcaxbRLmAuHtB8Ri0A</id>
    <link href="https://mp.weixin.qq.com/s/CSSqFcaxbRLmAuHtB8Ri0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>紫薯博士专栏 | 靶向巨噬细胞CD47的肿瘤药物研发进展</title>
    <updated>2020-11-25T07:18:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/MtFOX8bO3nXdf_V8tEu9CQ</id>
    <link href="https://mp.weixin.qq.com/s/MtFOX8bO3nXdf_V8tEu9CQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>呼吸之间——中国面临的肺癌挑战</title>
    <updated>2020-11-25T07:18:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/1n1emn-aZddu69VhzB_p9Q</id>
    <link href="https://mp.weixin.qq.com/s/1n1emn-aZddu69VhzB_p9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>十数年合作宣告结束，Amgen或将归还Omecamtiv Mecarbil 及AMG 594相关权益</title>
    <updated>2020-11-25T07:18:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/udQaXfKAiJh7hspFhE8QZw</id>
    <link href="https://mp.weixin.qq.com/s/udQaXfKAiJh7hspFhE8QZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>癌症患者早治疗有多重要？每延迟1个月，死亡率上升10%！《BMJ》最新超100万人研究</title>
    <updated>2020-11-25T07:18:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/C5GQwCulolKKxkIvn1ajOQ</id>
    <link href="https://mp.weixin.qq.com/s/C5GQwCulolKKxkIvn1ajOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药时代招聘 | 我们不做药，我们帮助做药的英雄们做好药！</title>
    <updated>2020-11-25T07:18:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/ezu4aUErFI_sdvqdspydSA</id>
    <link href="https://mp.weixin.qq.com/s/ezu4aUErFI_sdvqdspydSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫情下的华人之光！——热烈祝贺OncoImmune与默沙东达成4.25亿美元收购协议</title>
    <updated>2020-11-24T08:45:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/HWsSlY9QglYYxol_2FILng</id>
    <link href="https://mp.weixin.qq.com/s/HWsSlY9QglYYxol_2FILng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>明天早上9点！我们一起聊聊肺癌挑战与治疗的最新进展</title>
    <updated>2020-11-24T08:45:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/BI_-Aztdrb8M6JhPputtAg</id>
    <link href="https://mp.weixin.qq.com/s/BI_-Aztdrb8M6JhPputtAg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NCI科学家阐述肿瘤治疗特殊反应者产生的分子基础，为精准治疗提供新线索</title>
    <updated>2020-11-24T08:45:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/588aD6OupIcggfWk5VLdpg</id>
    <link href="https://mp.weixin.qq.com/s/588aD6OupIcggfWk5VLdpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>登顶《JAMA》！ct DNA到底和乳腺癌癌症患者预后到底有什么关系？</title>
    <updated>2020-11-24T08:45:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/h50jUedInpEq3KYVhVTypQ</id>
    <link href="https://mp.weixin.qq.com/s/h50jUedInpEq3KYVhVTypQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>下一个重磅炸弹：SHP2抑制剂研发进展</title>
    <updated>2020-11-24T08:45:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/DR62cyTAGz1OGDfv7dxSiQ</id>
    <link href="https://mp.weixin.qq.com/s/DR62cyTAGz1OGDfv7dxSiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>士别三日，礼来首付美元一个亿投身基因疗法，牵手Precision BioSciences共克遗传疾病</title>
    <updated>2020-11-23T07:39:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/Se6PzQJ6YLNmtmRKKYFgog</id>
    <link href="https://mp.weixin.qq.com/s/Se6PzQJ6YLNmtmRKKYFgog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《Nature》重磅！免疫治疗家族迎来新成员！从HPV疫苗说起......</title>
    <updated>2020-11-23T07:39:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/uMNQ6Xq0bJEHXmeBYHEdfg</id>
    <link href="https://mp.weixin.qq.com/s/uMNQ6Xq0bJEHXmeBYHEdfg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>